Ozone Therapy as a Possible Option in COVID-19 Management

[1]  D. Wang,et al.  The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status , 2020, Military Medical Research.

[2]  M. Dianzani,et al.  Lipid peroxidation and cancer. , 1993, Critical reviews in oncology/hematology.

[3]  E. Shacter.  QUANTIFICATION AND SIGNIFICANCE OF PROTEIN OXIDATION IN BIOLOGICAL SAMPLES* , 2000, Drug metabolism reviews.

[4]  R. Lerner,et al.  Evidence for Antibody-Catalyzed Ozone Formation in Bacterial Killing and Inflammation , 2002, Science.

[5]  G. Ricevuti,et al.  Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19. , 2020, European review for medical and pharmacological sciences.

[6]  Jing Liu,et al.  Updated Approaches against SARS-CoV-2 , 2020, Antimicrobial Agents and Chemotherapy.

[7]  B. K. Murray,et al.  Virion disruption by ozone-mediated reactive oxygen species. , 2008, Journal of virological methods.

[8]  A. Elvis,et al.  Ozone therapy: A clinical review , 2011, Journal of natural science, biology, and medicine.

[9]  Dong Yang,et al.  Inactivation of Poliovirus by Ozone and the Impact of Ozone on the Viral Genome. , 2019, Biomedical and environmental sciences : BES.

[10]  Arthur S Slutsky,et al.  Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target , 2020, Intensive Care Medicine.

[11]  R. S. Engelbrecht,et al.  Mechanism of enteroviral inactivation by ozone , 1981, Applied and environmental microbiology.

[12]  G. Ricevuti,et al.  Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures , 2020 .

[13]  S. Rozelle,et al.  Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review , 2020, Infectious Diseases of Poverty.

[14]  R. Rowen,et al.  A Plausible "Penny" Costing Effective Treatment for Corona Virus - Ozone Therapy , 2020 .

[15]  K. Hu,et al.  A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID‐19 , 2020, Journal of medical virology.

[16]  L. Bianchi,et al.  The Ozone Tolerance: I) Enhancement of Antioxidant Enzymes is Ozone Dose-Dependent in Jurkat Cells , 2003, Free radical research.

[17]  M. Montgomery,et al.  Sequential changes of lamellar body hydrolases during ozone-induced alveolar injury and repair. , 1989, The American journal of pathology.

[18]  G. Lin,et al.  Angiotensin‐converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS‐CoV‐2: A double‐edged sword? , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[20]  I. Parker.  Facts and figures. , 1973, The Probe.

[21]  G. Valacchi,et al.  The dual action of ozone on the skin , 2005, The British journal of dermatology.

[22]  G. Martínez-Sánchez,et al.  Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19 , 2020, Antioxidants.

[23]  C. Ferrando,et al.  Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19 , 2020, Revista Española de Anestesiología y Reanimación.

[24]  S. Ouf,et al.  Anti-fungal potential of ozone against some dermatophytes , 2016, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[25]  V. Bocci.  Scientific and medical aspects of ozone therapy. State of the art. , 2006, Archives of medical research.

[26]  M. Montgomery,et al.  Ozone stress initiates acute perturbations of secreted surfactant membranes. , 1991, The American journal of pathology.

[27]  Stephen H. Bell,et al.  A ?scoping review. , 2018, Sexual health.

[28]  S. Zanetti,et al.  Antibacterial activity of ozonized sunflower oil (Oleozon) , 2001, Journal of applied microbiology.

[29]  G. Fraedrich,et al.  Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management , 2007, Head & neck.

[30]  P. Papadakos,et al.  Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. , 2020, Revista espanola de anestesiologia y reanimacion.